The effect of curcumin on the premenstrual syndrome and dysmenorrhea

Phase 3

Recruiting

Conditions: Condition 1: Premenstrual syndrome. Condition 2: Dysmenorrhea.
Premenstrual tension syndrome
Primary dysmenorrhea
N94.3
N94.4

Registration Number: IRCT20120718010324N71

Lead Sponsor: Tabriz University of Medical Sciences

Brief Summary: Not available

Detailed Description: Not available

Recruitment & Eligibility

Status: Recruiting

Sex: Female

Target Recruitment: 62

Inclusion Criteria

Regular menstruation (21-35 days)
Having primary dysmenorrhea and premenstrual syndrome (with VAS score = 4 and PSST score = 20)
Age 18-25 years
Not allergic to turmeric
Not taking any medicine to treat the symptoms of premenstrual syndrome at the same time as the research

Exclusion Criteria

Abuse of tobacco and alcohol
Use of other herbal medicines
The occurrence of a stressful event (such as the death of a first-degree family member and the diagnosis of an incurable disease for a family member during the last three months)
Having any acute or chronic disease (such as epilepsy, cardiovascular, digestive, liver, blood, endocrine)
History of any gynecological disease, such as abnormal pelvic anatomy, lack of ovulation, or abnormal pattern of uterine bleeding.
Surgery in the last three months
Taking antidepressants (such as serotonin and noradrenaline reuptake inhibitors, antihistamines, barbiturates, narcotics, diazepam, amphetamines, and cocaine)
Taking anticoagulants such as heparin, aspirin, clopidogrel, dipyridamole, warfarin, enoxaparin and ticlopidine.

Study & Design

Study Type: interventional

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Premenstrual syndrome. Timepoint: The first assessment before entering the study and the second assessment in one month after the intervention and the third assessment in 2 months after the intervention. Method of measurement: Premenstrual symptoms screening tool (PSST).;Dysmenorrhea. Timepoint: The first assessment before entering the study and the second assessment in one month after the intervention and the third assessment in 2 months after the intervention. Method of measurement: Visual analogue scale (VAS).

Secondary Outcome Measures